1. Inhibition of the RAS and prevention of diabetes and CVD: Mechanistic insights and lessons learned from clinical trials

   • Samy I. McFarlane
   • Jeffrey S. Borer

   OriginalPaper 04 February 2009 Pages: 1 - 3

2. Preventing cardiovascular disease in type 2 diabetes: Where do things stand with glycemic control? Part one

   • Alan Chait

   Clinical Trials Report 04 February 2009 Pages: 7 - 8

3. Preventing cardiovascular disease in type 2 diabetes: Where do things stand with glycemic control? Part two

   • Alan Chait

   Clinical Trials Report 04 February 2009 Pages: 9 - 10

4. Managing diabetic dyslipidemia: Beyond statin therapy

   • Hemanth Neeli
   • Ram Gadi
   • Daniel J. Rader

   OriginalPaper 04 February 2009 Pages: 11 - 17

5. Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes

   • Michelle M. Averill
   • Karin E. Bornfeldt

   OriginalPaper 04 February 2009 Pages: 18 - 25

6. Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia

   • Dario A. Gutierrez
   • Michael J. Puglisi
   • Alyssa H. Hasty

   OriginalPaper 04 February 2009 Pages: 26 - 32

7. Weight loss and diets: Which diet works best?

   • Anders Carlson
   • Richard E. Pratley

   Clinical Trials Report 04 February 2009 Pages: 35 - 36

8. Metabolic syndrome associated with HIV and highly active antiretroviral therapy

   • Giuseppe Barbaro
   • Gialuca Iacobellis

   OriginalPaper 04 February 2009 Pages: 37 - 42

9. Dietary interventions for metabolic syndrome: Role of modifying dietary fats

   • Craig Lawrence Kien

   OriginalPaper 04 February 2009 Pages: 43 - 50

10. Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap

    • Roger S. McIntyre
    • Natalie L. Rasgon
    • Benjamin I. Goldstein

    OriginalPaper 04 February 2009 Pages: 51 - 59

11. The “legacy effect” associated with intensive glucose control in patients with type 2 diabetes

    • Jayanta T. Mukherjee
    • Richard W. Nesto

    Clinical Trials Report 04 February 2009 Pages: 63 - 64

12. Diabetes and cardiovascular disease: The role of glycemic control

    • Alice Y. Y. Cheng
    • Lawrence A. Leiter

    OriginalPaper 04 February 2009 Pages: 65 - 72

13. Type 2 diabetes and coronary heart disease: Focus on myocardial infarction

    • Rodrigo M. Lago
    • Richard W. Nesto

    OriginalPaper 04 February 2009 Pages: 73 - 78

14. The failing diabetic heart: Focus on diastolic left ventricular dysfunction

    • Loek van Heerebeek
    • Aernout Somsen
    • Walter J. Paulus

    OriginalPaper 04 February 2009 Pages: 79 - 86

15. Potential of glucose-lowering drugs to reduce cardiovascular events

    • Stuart W. Zarich

    OriginalPaper 04 February 2009 Pages: 87 - 94